WIG 2404
Alternative Names: WIG-2404Latest Information Update: 13 Feb 2026
At a glance
- Originator Whanin Pharmaceutical
- Class Antidepressants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Depressive disorders
Most Recent Events
- 29 Jan 2026 Early research in Depressive disorders in South Korea (unspecified route) (Whanin Pharmaceutical pipeline, January 2026)